Program

 

 

Day 1 - Saturday, 2 March 2019

 
 8:30 AMOpening of the workshop 
 Session 1: Current controversies for cART use in women of child bearing potential and in pregnancy
Chairs: Catherine Hankins and Karoline Aebi-Popp
 
 08:45 AM

Clinical case: Researcher perspective
Tendani Gaolathe, MD - Botswana Harvard AIDS Institute Partnership, Botswana

 
 

09:15 AM

Clinical case: Community perspective
Lucy Wanjiku Njenga - Positive Young Women Voices, Kenya

 
 09:45 AM

Clinical case: Policy implications
Meg Doherty, MD, PhD - WHO, UK

 
 10:15 AM Discussion 
 10:30 AMGroup Picture 
 10:45 AMCoffee Break 
    
  Abstract-driven presentations 
 11:15 AM

INSTI exposure and neural tube defects –
data from antiretroviral pregnancy registry
Jessica Albano, PhD, MPH - Syneos Health, USA

#1
 11:30 AM

Congenital anomalies in infants of Canadian women exposed to antiretrovirals including dolutegravir
Deborah Money, MD - UBC, Canada

#2
 11:45 AM

Evaluation of neural tube defects after exposure to Raltegravir
during pregnancy

Hala Shamsuddin, MD - Merck, USA

#3 
 12:00 PMPanel discussion:  debaters, community, presenters 
    
  12:30 PMLunch
 
    
 Session 2: New drug delivery systems, are they right for women?
Chair: Sharon Walmsley
 
 01:30 PM

Invited lecture, focus on cabotegravir
Annemiek de Ruiter, MBBS FRCP, MD, ViiV Healthcare, UK

 
 02:00 PM


Emerging drug delivery systems for treatment and prevention of HIV

Kimberly Scarsi, PharmD, MS, University of Nebraska, USA

 
  Abstract-driven presentations
 
 02:30 PM

Clinical development strategy to inform dosing of antiretroviral drugs
in women: dolutegravir as a case study

Kimberly Adkison, PhD - Viiv Healthcare, USA

#4
 2:45 PM

HIV risk and characteristics of women seeking PrEP
in a US demonstration project
Jill Blumenthal, MD - University of California, San Diago, USA

#5
 03:00 PMDiscussion 
    
 03:15 PMCoffee Break 
    
 Session 3: Unique challenges of growing up with HIV
Chairs: Angelina Namiba and Teresia Otieno
 
 03:45 PM
Invited lecture: Unique challenges of growing up with HIV

Vanessa, CHIVA, UK
 
  Abstract-driven presentations 
 04:15 PMOptimizing HIV service delivery for young women who sell sex:
a discrete choice experiment
Sue Napierala, PhD, MPH - RTI International, USA
#6
 04:30 PMHigh PrEP uptake among HIV-exposed women with pregnancy plans
in South Africa
Lynn Matthews, MD - University of Alabama at Birmingham, USA
#7
 04:45 PMInnovative intervention for pregnant and breastfeeding adolescent mothers to enhance viral suppression in Homa Bay County, Kenya
Elizabeth Okoth (presented by N. Rakhmanina), MPH -
Elizabeth Glaser Pediatric AIDS Foundation, Kenya
#8
 05:00 PMDiscussion 
    
 5:15 PMWelcome drinks and poster viewing session 1 
  Guided poster tour 1: ARV and pregnancy issues  
  Altered levels of bioactive lipids in HIV and cART-exposed pregnancy
Kayode Balogun 
#14
  Double-Dose Levonorgestrel Implant Does Not Fully Overcome
Drug-Drug Interaction with Efavirenz

Kimbery Scarsi 
#15
  Lopinavir (an HIV protease inhibitor) impairs uterine remodeling
during pregnancy

Smriti Kala 
#16
  Adverse pregnancy outcomes in HIV-positive pregnant women
on ART in Kenya

Lisa Abuogi 
#17
  Adoption of an HIV-neutral approach to pregnancy care
in San Francisco, California

Dominika Seidman 
#18
  Early antenatal care visit as it relates to prevention of
mother to child transmission of HIV in sub-Saharan Africa

Adewale Adefila 
#19
    
 07:00 PMNetworking dinner 
    
 

Day 2 - Sunday, 3 March 2019

 
 Session 4: Healthy aging with HIV for women
Chair: Margaret Johnson
 
 08:30 AM
Bone Health among women aging with HIV
Michael Yin, MD, New York State Psychiatric Institute & Columbia University, USA
 
 09:00 AM
Cardiac Muscle Health Among Women Aging with HIV
Markella Zanni, MD, MGH/Harvard Medical School, USA
 
 09:30 AM
Important Drug- Drug interactions in Women aging with HIV
Marta Boffito, MD, PhD, SSAT & Imperial College, Chelsea and Westminster Hospital, UK
 
 10:00 AMDiscussion 
    
 10:15 AMCoffee break and poster viewing session 2 
  Guided poster tour 2: ARV in women  
  Efficacy of two-drug regimen of dolutegravir plus lamivudine (DTG+3TC) versus dolutegravir plus tenofovir/emtricitabine (DTG+TDF/FTC) at 48 weeks in antiretroviral naïve women: GEMINI studies subgroup analysis
Romina Quercia 
#20
  Tenofovir Alafenamide vs Tenofovir DF in women: pooled analysis of 7 clinical trials
Melanie Thompson 
#21
  Week 48 Safety and Efficacy of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Women in the BRIGHTE Study
Peter Ackerman 
#22
  Efficacy and Safety of the Once-daily Darunavir/Cobicistat/
Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Single-tablet Regimen in Antiretroviral Treatment (ART)-experienced and ARTnaïve Women Living with HIV-1: EMERALD and AMBER Week 96 Results

Aimee Wilkin 
#23
    
  Guided poster tour 3: Comprehensive care in women  
  Prevalence of Cervical Dysplasia in HIV-positive Women Versus
HIV-negative Women: The Case of Zambia

Aimee Rurangwa 
#24
  Reflections on a specialist HIV menopause service
Roberta Brum 
#25
  38% of child bearing women with HIV in the UK would like to breastfeed-Results from PACIFY study group
Farai Nyatsanza 
#26
  Risk of hospitalisation according to gender and ethnicity among
people living with HIV in the modern ART era

Sophia Rein 
#27
  Depression symptom trajectories among mothers
living with HIV in rural Uganda

Itziar Familiar 
#28
  Development and piloting of a scale to measure trauma- and
violence-aware principles of HIV care and practice for women
living with HIV in Metro Vancouver, Canada

Kathleen Deering 
#29
    
 Session 5: Research in women and HIV - 1
Chairs:  Markella Zanni and Patricia Vasquez
Abstract-driven presentations
 
 11:30 AMNon-Vaccine Oncogenic HPV Persistence Among
HPV-Vaccinated Women Living with HIV

Elisabeth McClymont - University of British Columbia, Canada
#9
 11:45 AMDolutegravir pharmacokinetics during pregnancy and postpartum
Angela Colbers, PhD - Radboud University Medical Center, The Netherlands
#10
 12:00 AMIntimate Partner Violence, Depression, and Mortality among a Cohort
of Women living with HIV Marginalized by Socio-structural Inequities
in Vancouver, Canada

Kalysha Closson - University Of British Columbia, Canada
#11
  12:15 AMVaginal microbiome and associations with tenofovir diphosphate and lamivudine triphosphate in cervical tissues of Ugandan women
Melanie Nicol, PharmD, PhD - University of Minnesota, USA
 #12
    
 12:30 PMLunch 
    
 Session 6: HIV cure research - considerations for women
Chair: Natella Rakhmanina
 
 01:30 PM
HIV Cure: Where have we been, where are we going?
Daniel Kuritzkes, MD, Harvard Medical School, USA
 
 02:00 PM


Invited lecture:  Focus on women
Jintanat Ananworanich, MD, PhD,

US Military HIV Research Program, USA

 
  Abstract-driven presentation 
 02:30 PMWomen’s involvement in clinical research: Women included
in Dolutegravir clinical trials versus collaborative studies

Romina Quercia, MD, PhD, MPH - ViiV Healthcare, UK
#13
 02:45 PMDiscussion 
    
 03:00 PMClosing of the workshop